1-2 of 2
Brad Rovin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol.

Kristie A. Blum, MD, Amy S. Ruppert, Jennifer A. Woyach, MD, Jeffrey A. Jones, MD, MPH, Leslie Andritsos, MD, Joseph M. Flynn, DO, MPH, Brad Rovin, MD, Miguel Villalona-Calero, MD, Jia Ji, Mitchell Phelps, PhD, Amy J. Johnson, PhD, Michael R. Grever, M.D., John C. Byrd, MD
Journal: Blood
Blood (2010) 116 (21): 1386.
https://doi.org/10.1182/blood.V116.21.1386.1386
Published: 2010
Journal Articles

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia

Clinical Trials & Observations
John C. Byrd, Thomas S. Lin, James T. Dalton, Di Wu, Mitch A. Phelps, Beth Fischer, Mollie Moran, Kristie A. Blum, Brad Rovin, Michelle Brooker-McEldowney, Sarah Broering, Larry J. Schaaf, Amy J. Johnson, David M. Lucas, Nyla A. Heerema, Gerard Lozanski, Donn C. Young, Jose-Ramon Suarez, A. Dimitrios Colevas, Michael R. Grever
Journal: Blood
Blood (2006) 109 (2): 399–404.
https://doi.org/10.1182/blood-2006-05-020735
Published: 2006